Telix Pharmaceuticals (TLPPF) Shares Outstanding (Entity) (2023 - 2025)
Powered by 
Analysis
Telix Pharmaceuticals (TLPPF) Shares Outstanding (Entity) (2023 - 2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Entity.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 212.49 Bn | 198.50 Bn | 7.24 Bn | 540.60 Mn |
| 2 | Gilead Sciences | 180.93 Bn | 177.75 Bn | 6.22 Bn | 1.24 Bn |
| 3 | Vertex Pharmaceuticals | 132.39 Bn | 124.53 Bn | 2.84 Bn | 253.35 Mn |
| 4 | Regeneron Pharmaceuticals | 82.17 Bn | 74.18 Bn | 3.93 Bn | 102.80 Mn |
| 5 | Argenx Se | 61.05 Bn | 55.87 Bn | 1.37 Bn | - |
| 6 | Moderna | 55.19 Bn | 50.05 Bn | 52.00 Mn | 399.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.99 Bn | 30.68 Bn | 992.69 Mn | 133.73 Mn |
| 8 | Biogen | 31.30 Bn | 30.01 Bn | 1.96 Bn | 147.75 Mn |
| 9 | Roivant Sciences | 29.91 Bn | 29.91 Bn | 1.16 Mn | 722.67 Mn |
| 10 | Telix Pharmaceuticals | 3.72 Bn | 3.43 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 338.78 Mn |
| Dec 31, 2024 | 334.72 Mn |
| Dec 31, 2023 | 323.73 Mn |